Lanie E. Happ
Impact in
-
- Lymphoma Diagnosis and Treatment
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 7
-
- Ubiquitin and proteasome pathways 1
- Protein Degradation and Inhibitors 1
- Co-authors
- Sandeep S. Davé (9 shared papers)Anupama Reddy (3 shared papers)Cassandra Love (4 shared papers)Jie Wang (1 shared paper)Wesley Huang (1 shared paper)Tushar Dave (1 shared paper)Xiang Li (1 shared paper)Wenbin Xiao (2 shared papers)
- Journals
- Blood (3 papers)American Journal of Clinical Pathology (2 papers)Journal of Clinical Oncology (1 paper)Cold Spring Harbor Perspectives in Medicine (1 paper)JCI Insight (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Lanie E. Happ
9 papers receiving 44 citations
Peers
Comparison fields: 5 of 22
- Pathology and Forensic Medicine 18
- Genetics 9
- Oncology 20
- Immunology 12
- Cancer Research 8
Countries citing papers authored by Lanie E. Happ
This map shows the geographic impact of Lanie E. Happ's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanie E. Happ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanie E. Happ more than expected).
Fields of papers citing papers by Lanie E. Happ
This network shows the impact of papers produced by Lanie E. Happ. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanie E. Happ. The network helps show where Lanie E. Happ may publish in the future.
Co-authors
The 25 scholars most cited alongside Lanie E. Happ, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 11 | |
| 2 | 2018 | 10 | |
| 3 | 2021 | 8 | |
| 4 | 2023 | 5 | |
| 5 | 2018 | 3 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 2 | |
| 8 | 2021 | 1 | |
| 9 | 2022 | 1 |
About Lanie E. Happ
Lanie E. Happ is a scholar working on Pathology and Forensic Medicine, Molecular Biology, Genetics, Oncology and Surgery, having authored 9 papers that have together received 44 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Ubiquitin and proteasome pathways (1 paper), Acute Lymphoblastic Leukemia research (1 paper), Cancer Genomics and Diagnostics (1 paper), Protein Degradation and Inhibitors (1 paper) and Viral-associated cancers and disorders (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (18 citations), Genetics (9 citations), Oncology (20 citations), Immunology (12 citations) and Cancer Research (8 citations). Lanie E. Happ has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Sandeep S. Davé, Anupama Reddy, Cassandra Love, Jie Wang, Wesley Huang, Tushar Dave, Xiang Li, Wenbin Xiao, David G. Kirsch and Mohit Sachdeva. Their work appears in journals such as Blood, American Journal of Clinical Pathology, Journal of Clinical Oncology, Cold Spring Harbor Perspectives in Medicine and JCI Insight.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.